<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000802853">
  <TermName>TNBC</TermName>
  <TermDefinition>
    <DefinitionText>A type of breast cancer in which the tumor cells do not have estrogen receptors, progesterone receptors, or large amounts of HER2/neu protein on their surface. Knowing whether breast cancer is triple negative is important in planning treatment.  Also called ER-negative PR-negative HER2/neu-negative breast cancer and triple-negative breast cancer.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <TermDefinition>
    <DefinitionText>TNBC is defined by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu). Also called ER-negative PR-negative HER2/neu-negative breast cancer and triple-negative breast cancer.</DefinitionText>
    <Dictionary>Genetics</Dictionary>
    <Audience>Health professional</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000815446" type="image/jpeg" alt="Drawing showing a triple-negative breast cancer cell with the estrogen receptor, progesterone receptor, and HER2 proteins crossed out with a black &quot;X&quot; mark. This means that the breast cancer cell does not have these proteins." language="en" audience="Patients" placement="image-center" id="_5">
    <Caption language="en">Triple-negative breast cancer is a type of breast cancer in which the cancer cells do not have estrogen receptors, progesterone receptors, or large amounts of HER2/neu protein on their surface.</Caption>
  </MediaLink>
  <SpanishTermName>TNBC</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Tipo de cáncer de mama cuyas células tumorales no tienen en su superficie receptores de estrógeno, receptores de progesterona ni cantidades altas de la proteína HER2/neu. Para planificar el tratamiento, es importante saber si el cáncer de mama es triple negativo. También se llama cáncer de mama negativo para ER, PR y HER2/neu, cáncer de mama triple negativo y CMTN.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <SpanishTermDefinition>
    <DefinitionText>Este tipo de cáncer de mama se define por ausencia de expresión del receptor de estrógeno (ER), el receptor de progesterona (PR) y el receptor 2 del factor de crecimiento epidérmico humano (HER2/neu). También se llama cáncer de mama negativo para ER, PR y HER2/neu, cáncer de mama triple negativo y CMTN.</DefinitionText>
    <Dictionary>Genetics</Dictionary>
    <Audience>Health professional</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2020-09-23</DateFirstPublished>
  <DateLastModified>2024-10-03</DateLastModified>
</GlossaryTerm>
